Blood Pressure Assessment in Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- Registration Number
- NCT01088269
- Lead Sponsor
- University of Athens
- Brief Summary
This is a cross-sectional study including patients with permanent atrial fibrillation. Assessment will include:
* clinic blood pressure measurements (mercury sphygmomanometer and automated oscillometric device)
* 24-hour ambulatory blood pressure monitoring
* determination of various serum markers and cardiac ultrasound.
* evaluation of a 24h ambulatory blood pressure monitoring device (Microlife WatchBPO3) in terms of its diagnostic value for the detection of atrial fibrillation compared with the reference 24h Holter ECG
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- Hypertensives adults in atrial fibrillation
- Renal disease (Cr > 2 mg/l).
- Patients with pacemaker rhythm during the study.
- Each patient with acute disease (inflammation, surgery), malignancy, collagen diseases, pulmonary fibrosis, renal failure, liver failure, chronic inflammatory diseases.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood Pressure Measurement in Atrial Fibrillation,Serum Markers and echocardiographic indexes in atrial fibrillation (AF) Baseline 1. Evaluation of the oscillometric technique of an electronic device in blood pressure measurement.
2. Evaluation of the relationship of blood pressure levels with serum markers and ultrasonographic cardiac indexes.
3. Evaluation of a 24h ambulatory blood pressure monitoring device (Microlife WatchBPO3) in terms of its diagnostic value for the detection of atrial fibrillation compared with the reference 24h Holter ECG
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hypertension Center, Third Internal Medicine Dpt, University of Athens
🇬🇷Athens, Greece